With the dawn of DNA sequencing, wearable technologies, and big data applications such as artificial intelligence and machine learning, detailed characterization of human biology and behaviors is now possible at an unprecedented scale. This is reflected in the rise of global population studies, creating opportunities...
Q: What is your responsibility when selecting and/or working with these early stage companies? A: NCI SBIR Program Directors do not play a role in reviewing the SBIR/STTR applications. That process is done at the NIH Peer Review panel....
Q: There are various new, emerging therapeutics that bring us closer towards a cure for life-threatening disorders such as cancer, HIV, or Huntington’s disease. Prominent examples include the popular gene editing tool CRISPR or new and improved cell and gene therapies. By when can we...
With the dawn of DNA sequencing, wearable technologies, and big data applications such as artificial intelligence and machine learning, detailed characterization of human biology and behaviors is now possible at an unprecedented scale. This is reflected in the rise of global population studies, creating opportunities...
Q: Your current focus is on creating a large-scale biomedical data analytics platform, a “data lake” that aggregates and provides access to various types of data, including EMR, omics, clinical data, ECG, imaging, population health, and wearable devices data and is linked for analytical access...
Q: Helix is involved in a number of major population initiatives that have recently been launched. can you tell us more about these initiatives - what are their goals and what is Helix’s role? A: We are proud to work with health systems across the US...
Gender bias and minority health in our medical system can have serious and sometimes fatal repercussions. These inequalities are now being addressed with intensive and collaborative efforts at all levels of research and in the clinical setting....
Q: The prevalence of metabolic syndrome in patients with schizophrenia is much higher compared to the general population. What is the role of folate pharmacogenomics on inflammatory and metabolic complications from atypical antipsychotic use in schizophrenia? A: The folate hypothesis of schizophrenia is an emerging field...
Q: Cancer Genomic Profiling is being used more routinely as standard of care in many cancer types. To date, it has been used to determine what therapies are most likely to work on that tumor, prognosis for that patient, and to uncover clinical trial...
Q: Interpreting data at the point of care has its challenges, especially when it comes to integrating the various types of data for combined analysis and clinical applications (e.g. clinical, imaging, and genomics data). What are some of the challenges the industry is facing and...
